Ceftazidime-avibactam is a combination agent consisting of the β-lactamase inhibitor avibactam and the broad-spectrum cephalosporin ceftazidime. There are no published case reports or studies evaluating the use of CAZ-AVI in pediatric critically ill patients. We report a case of a successful treatment of septic shock due to Klebsiella pneumonie (KP) in a 14-years-old boy (body weight 50 kg) admitted in intensive care unit (ICU).
Successful treatment of KPC-MDR septic shock with ceftazidime-avibactam in a pediatric critically ill patient / Vargas, M.; Buonomo, A. R.; Buonanno, P.; Iacovazzo, C.; Servillo, G.. - In: IDCASES. - ISSN 2214-2509. - 18:(2019), p. e00634. [10.1016/j.idcr.2019.e00634]
Successful treatment of KPC-MDR septic shock with ceftazidime-avibactam in a pediatric critically ill patient
Vargas M.;Buonomo A. R.;Buonanno P.;Iacovazzo C.;Servillo G.
2019
Abstract
Ceftazidime-avibactam is a combination agent consisting of the β-lactamase inhibitor avibactam and the broad-spectrum cephalosporin ceftazidime. There are no published case reports or studies evaluating the use of CAZ-AVI in pediatric critically ill patients. We report a case of a successful treatment of septic shock due to Klebsiella pneumonie (KP) in a 14-years-old boy (body weight 50 kg) admitted in intensive care unit (ICU).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
